Patent · US Active

Transdermal delivery system for treating infertility

US8372806B2 · kind B2 · utility

54Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 6, 2006
Grant dateFeb 12, 2013
Priority date
Expiry dateOct 29, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B2018/00452
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The transdermal delivery system for treating infertility in a patient comprises an apparatus (10) for facilitating transdermal delivery of a drug (5a) through an area of the apparatus (10) comprises an ablator that is configured to generate a microporation in the area of the skin of the patient, and comprises a drug (5a), wherein the drug effects at least one of the biological regulation of at least one oocyte containing follicle, stimulation of follicle growth, induction of ovulation, promotion of gestational status, maintenance of conceptus, maintenance of pregnancy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.